Managing adult asthma during the COVID-19 pandemic: A 2022 review and current recommendations

Authors:

Abstract
Asthma is the most prevalent chronic respiratory disease, estimated to affect more than 300 million people worldwide.1 First recognised in December 2019, the coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has evolved into an ongoing global pandemic.2 In May 2020, a summary of recommendations for

This publication has 46 references indexed in Scilit: